khk2455
Small moleculeexperimental
Clinical trial activity
3 trials · 3 clinical orgs · 0 marketing orgs
Phase 1
2
Phase 2
0
Phase 3
0
Phase 4
0
Earliest trial started Aug 1, 2016 (NCT02867007)
Timeline
2010s
- Jan 1, 2016
Earliest Phase 1 Sponsor(trial)
Indications
Mechanism of action
- Indoleamine 2,3-dioxygenaseINHIBITOR
IDO1 inhibitor
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- khk2455
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT03915405 | Phase 1 | Apr 15, 2019 | Kyowa Kirin |
| NCT02867007 | Phase 1 | Aug 1, 2016 | Kyowa Hakko Kirin |
| NCT04321694 | N/A | — | Kyowa Kirin, University of New Mexico |
Showing 3 of 3 trials
Page 1 / 1
Organizations
Research & Development (3)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Kyowa Kirin | For profit | 2 | 2 | 2 | 2019 |
| Kyowa Hakko Kirin | For profit | 1 | 1 | 1 | 2016 |
| University of New Mexico | Academic/Hospital | 1 | 0 | 1 | — |
3 organizations
Page 1 / 1